ME 2303
ME 2303 (FAD 104) is a fluoro-pyranosyl adriamycin analogue with anti-tumor potential. ME 2303 can inhibit the proliferation of acute undifferentiated myeloblastic leukemia (AML) blast cells in a dose-dependent manner. ME 2303 can be used for the study of acute undifferentiated myeloblastic leukemia (AML) [1].
Product Specifications
CAS Number
116521-53-0
Product Name Alternative
FAD 104
UNSPSC
12352005
Target
Others
Related Pathways
Others
Field of Research
Cancer
Smiles
OC1=C2C([C@H](C[C@@](C(COC(CCCCCC(O)=O)=O)=O)(O)C2)O[C@@]3([H])[C@@H]([C@@H]([C@H](O)[C@H](C)O3)O)F)=C(O)C4=C1C(C5=CC=CC(OC)=C5C4=O)=O
Molecular Formula
C34H37FO15
Molecular Weight
704.65
References & Citations
[1]Blazsek I, et al. The differentiation-promoting potential of a cytostatic fluoro-pyranosyl adriamycin analog (FAD 104) . Biomed Pharmacother. 1989;43 (4) :267-70.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680050-100 1x 100 µL
IgA Secretory Component (SC05), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470460-100 1x 100 µL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040525-100 1x 100 µL
CD63 (MX-49.129.5), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details